PNC Financial Services Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

PNC Financial Services Group’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-54	Closed	-$2.14K	–	4955
2024 Q1	$2.14K	Buy	+54	New	+$1.59K	﹤0.01%	4180

PNC Financial Services Group's ALPN Position: Q2 2024 in Review

PNC Financial Services Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 54 shares — an estimated $2.14K sold.

PNC Financial Services Group first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $2.14K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

PNC Financial Services Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
PNC Financial Services Group sold 54 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $2.14K.
PNC Financial Services Group first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
PNC Financial Services Group's Alpine Immune Sciences Inc position peaked at $2.14K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.